Cancer BiologybioRxiv
CMTM6 drives cisplatin resistance in OSCC by regulating AKT mediated Wnt signaling
P. Mohapatra, O. Shriwas, S. Mohanty…·R. Dash
This study identifies CMTM6 as a driver of cisplatin resistance in OSCC by activating AKT-mediated Wnt signaling, leading to increased survival gene expression and tumor growth.
DOI 10.1172/jci.insight.143643